BRIGHAM MICHAEL F 4
4 · IMMUCELL CORP /DE/ · Filed Feb 9, 2022
Insider Transaction Report
Form 4
BRIGHAM MICHAEL F
DirectorPresident & CEO
Transactions
- Award
Incentive Stock Options (Right to buy)
2022-01-31$8.15/sh+1,000$8,150→ 1,000 totalExercise: $8.15From: 2025-01-31Exp: 2032-01-31→ Common Stock (1,000 underlying)
Footnotes (1)
- [F1]This stock option grant is made subject to the reservation of more shares for the Company's 2017 Stock Option Plan by vote of stockholders at the 2022 Annual Meeting of the Company.